SCHEMBL1825933

SCHEMBL1825933

CCc1cc(N)c(CC)c(Cl)c1Cc1c(CC)cc(N)c(CC)c1Cl

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.36
TAAR1 Q96RJ0 1/20 0.33
MAP4K1 Q92918 1/20 0.30
GABRP O00591 1/20 0.30
GABRD O14764 1/20 0.30
GABRA1 P14867 1/20 0.30
GABRB1 P18505 1/20 0.30
GABRG2 P18507 1/20 0.30
GABRB3 P28472 1/20 0.30
GABRA5 P31644 1/20 0.30
GABRA3 P34903 1/20 0.30
GABRA2 P47869 1/20 0.30
GABRB2 P47870 1/20 0.30
GABRA4 P48169 1/20 0.30
GABRE P78334 1/20 0.30
GABRA6 Q16445 1/20 0.30
GABRG1 Q8N1C3 1/20 0.30
GABRG3 Q99928 1/20 0.30
GABRQ Q9UN88 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL817016 0.84 DHFR (0.36) DHFRMAP4K1
SCHEMBL17203755 0.79 DHFR (0.34) DHFRMAP4K1
SCHEMBL394710 0.76 NOS3 (0.39) DHFRMAP4K1GABRPGABRDGABRA1
SCHEMBL11230051 0.75 CYP3A4 (0.35) DHFRTAAR1MAP4K1
SCHEMBL9799254 0.74 POLB (0.38) DHFRMAP4K1
SCHEMBL3678947 0.73 ALDH1A1 (0.34) DHFR
SCHEMBL10342242 0.72 DHFR (0.39) DHFRMAP4K1
SCHEMBL3678945 0.72 DHFR (0.36) DHFR
SCHEMBL28319291 0.72 SMN1; SMN2 (0.31) DHFR
SCHEMBL11800708 0.71 CTRC (0.36) MAP4K1GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949589-B2 Elastic foamed grinder material and method for producing the same OYAIZU YOSHIJIRO 2005-09-27 US claimed
US-20030066245-A1 Elastic foamed grinder material and method for producing the same OYAIZU YOSHIJIRO (JP) 2003-04-10 US claimed
US-10280333-B2 Coating compositions Seagrave Coatings Corp. (US) 2019-05-07 US disclosed
EP-3061622-A1 COATING COMPOSITIONS Seagrave Coating Corp. (US) 2016-08-31 EP disclosed
US-20160237309-A1 SOLVENT-FREE POLYURETHANE 100% SOLIDS COATING SEAGRAVE COATINGS 2016-08-18 US disclosed
EP-2318450-B1 NOVEL CURING AGENTS AND PROCESS FOR THEIR MANUFACTURE HEXCEL COMPOSITES LTD (GB) 2014-02-26 EP disclosed
US-8461275-B2 Curing agents and process for their manufacture Hexcal Composites Limited (GB) 2013-06-11 US disclosed
US-20110130525-A1 NOVEL CURING AGENTS AND PROCESS FOR THEIR MANUFACTURE Hexcel Corporation Ltd (GB) 2011-06-02 US disclosed
EP-2318450-A2 NOVEL CURING AGENTS AND PROCESS FOR THEIR MANUFACTURE Hexcel Composites Limited (GB) 2011-05-11 EP disclosed
WO-2010018392-A2 NOVEL CURING AGENTS AND PROCESS FOR THEIR MANUFACTURE HEXCEL COMPOSITES LIMITED (GB) 2010-02-18 WO disclosed
US-6949589-B2 Elastic foamed grinder material and method for producing the same OYAIZU YOSHIJIRO 2005-09-27 US disclosed
US-20030066245-A1 Elastic foamed grinder material and method for producing the same OYAIZU YOSHIJIRO (JP) 2003-04-10 US disclosed
US-5955199-A LAMINATED VEHICLE PART COMPRISING SHEET MOLDING COMPOUND SUBSTRATES ADHERED TOGETHER WITH ADHESIVE COMPRISING ISOCYANATE TERMINATED PREPOLYMER, CURATIVE MIXTURE OF POLYOL, POLYAMINE, POLYKETIMINE OR POLYALDIMINE ASHLAND INC. (US) 1999-09-21 US disclosed
WO-1999016619-A1 IMINE-CONTAINING CURATIVE FOR TWO COMPONENT POLYURETHANE STRUCTURAL ADHESIVES ASHLAND INC. (US) 1999-04-08 WO disclosed
US-5880180-A THERMOSETTING RESIN COMPOSITION FOR SHEET MOLDING COMPRISING UNSATURATED POLYESTER, UNSATURATED MONOMER, LOW PROFILE ADDITIVE, AROMATIC ALDIMINE SURFACE QUALITY ENHANCER ASHLAND INC. (US) 1999-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110130525-A1 NOVEL CURING AGENTS AND PROCESS FOR THEIR MANUFACTURE ARCN1, PUF60, RCOR1 DHFR 1146/4885TAAR1 2691/4885MAP4K1 3882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.